Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Matthieu Coq"'
Autor:
Anna Tancin Lambert, Xiang Y. Kong, Barbara Ratajczak-Tretel, Dan Atar, David Russell, Mona Skjelland, Vigdis Bjerkeli, Karolina Skagen, Matthieu Coq, Eric Schordan, Huseyin Firat, Bente Halvorsen, Anne H. Aamodt
Publikováno v:
Cerebrovascular Diseases Extra, Vol 10, Iss 1, Pp 11-20 (2020)
Background and Purpose: Cardioembolic stroke due to paroxysmal atrial fibrillation (AF) may account for 1 out of 4 cryptogenic strokes (CS) and transient ischemic attacks (TIAs). The purpose of this pilot study was to search for biomarkers potentiall
Externí odkaz:
https://doaj.org/article/0df8b56b358945ba95d9499b2fb02d2b
Autor:
Barbara Ratajczak-Tretel, Dan Atar, Anna Tancin Lambert, Huseyin Firat, Matthieu Coq, Eric Schordan, Xiang Yi Kong, David Russell, Karolina Skagen, Bente Halvorsen, Anne Hege Aamodt, Vigdis Bjerkeli, Mona Skjelland
Publikováno v:
Cerebrovascular Diseases Extra, Vol 10, Iss 1, Pp 11-20 (2020)
Cerebrovascular Diseases Extra
Cerebrovascular Diseases Extra
Background and Purpose: Cardioembolic stroke due to paroxysmal atrial fibrillation (AF) may account for 1 out of 4 cryptogenic strokes (CS) and transient ischemic attacks (TIAs). The purpose of this pilot study was to search for biomarkers potentiall
Autor:
M. Mehdi, Christian Jorgensen, Sami Ait Abbi Nazi, Hüseyin Firat, Matthieu Coq, Eric Schordan
Publikováno v:
Saturday, 15 June 2019.
Background: Rheumatoid Arthritis (RA) is a chronic, progressive, inflammatory autoimmune disease associated with articular, extra-articular and systemic effects leading to joint destruction. T cells, B cells and the orchestrated interaction of pro-in
Autor:
Christian Jorgensen, Matthieu Coq, M. Mehdi, Yves-Marie Pers, Hüseyin Firat, Florence Apparailly, Sabrina Danilin
Publikováno v:
Saturday, 15 June 2019.
Background: Today the objective for efficient Rheumatoid Arthritis (RA) therapy is not restricted to reduced synovial inflammation but to induce immunological and clinicaly lasting remission. Despite improvement in therapy of RA, anti-TNF alpha or an
Autor:
M. Schumacher, Eric Schordan, Sabrina Danilin, M. Mehdi, Hüseyin Firat, Twj Huizinga, Matthieu Coq
Publikováno v:
Annals of the Rheumatic Diseases
Background Anti-TNF alpha biologicals are an important breakthrough in the treatment of Rheumatoid Arthritis (RA) patients. However, 30–40% of RA patients do not respond to these therapies. Therefore, there is an unmet need for a tool to predict tr
Autor:
G. Bilger, M. Schumacher, Matthieu Coq, Sabrina Danilin, Eric Schordan, Hüseyin Firat, M. Mehdi
Publikováno v:
Annals of the Rheumatic Diseases. 75:228.1-228
Background Millions of patients suffering Rheumatoid Arthritis (RA) are treated with TNF-α inhibiting agents, however, response rate is low (30 to 40%) and no tool exists to predict the treatment response. Objectives Using the HTG-Edgeseq platform,